Organization: Patented Medicine Prices Review Board Canada
Year: 2022
Month: September
Request Number: A-2022-01918
Request Summary: Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.
Disposition: All exempted
Number of pages: 0